CLINICAL STUDY ON THE COMBINED EFFECT ON VIRECHANA KARMA (PURGATION THERAPHY) FOLLOWED BY HAMSAPADYADI KASHAYA (HERBAL DECOCTION) AND PIPPALI KSHEERAPAKA PRAYOGA (MEDICATED MILK PREPARATION) IN HYPOTHYROIDISM

AN OPEN LABEL SINGLE ARM STUDY ON THE COMBINED EFFECT ON VIRECHANA KARMA FOLLOWED BY HAMSAPADYADI KASHAYA AND PIPPALI KSHEERAPAKA PRAYOGA IN HYPOTHYROIDISM - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035842

Enrollment

Registered

2021-08-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E038- Other specified hypothyroidism

Interventions

Intervention1: Virechana Karma Hamsapadyadi Kashaya Pippali Ksheerapaka : Virechana karma for 15 days followed by oral administration of Hamsapadyadi Kashaya 24ml with Lukewarm water before food tw

Eligibility

Inclusion criteria

Inclusion criteria: Subjects between the age group of 20 and 60 years of either gender Subjects presenting with signs and symptoms of Hypothyroidism Serum T3 T4 and TSH levels which indicates Hypothyroidism Subjects who are freshly diagnosed as Hypothyroidism without medications but presenting with the Diagnostic criteria are included Subjects who are fit for Virechana karma will be taken

Exclusion criteria

Exclusion criteria: Subjects who have under gone any type of thyroid surgery Subjects suffering from systemic diseases like Cardiac disorders uncontrolled Diabetes Mellitus and Hypertension Carcinoma Sepsis Subjects suffering from congenital hypothyroidism drug induced hypothyroidism Myxoedema coma neoplasia toxic goitre are excluded Pregnant women and Lactating mothers

Design outcomes

Primary

Measure	Time frame
To evaluate the combined effect of Virechana Karma followed by Hamsapadyadi Kashaya and Pippali Ksheera Paka Prayoga in Hypothyroidism and thereby evaluating the reduction in signs and symptoms of Hypothyroidism and Serum T3 T4 and TSH levelTimepoint: 45 days	—

Secondary

Measure	Time frame
NIL Timepoint: Not Applicable	—

Countries

India

Contacts

Public ContactDr Abdul Khader

Sri Kalabyraveshwaraswamy Ayurvedic Medical College Hospital and Research Centre

abukaya2003@gmail.com9845199790

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026